Abstracts

Genetic Variants of ABCC2 and ABCC10 Are Associated With TFV-Induced Proximal Tubular Dysfunction

Background: Tenofovir (TFV) is an effective and widely used treatment for both HIV and hepatitis B virus infection. However, it’s use in some patients leads to proximal renal tubular dysfunction (PRTD). We aimed to determine the association between polymorphisms in genes encoding drug transporters and PRTD in Thai patients treated with TFV. Methodology: PRTD was…

Atazanavir and Tenofovir Attenuate the Benefit of Antiretroviral Therapy on Cystatin C: ACTG A5224

Background: Plasma cystatin C is a biomarker of kidney function thought to more accurately reflect glomerular filtration rate (GFR) than serum creatinine. Whether inflammation affects cystatin C concentrations is controversial. The differential effects of antiretroviral therapy (ART) on cystatin C are poorly understood. Methodology: ACTG A5224s was a substudy of A5202 which randomly assigned 1857…

Renal and Metabolic Safety of Initial HIV-1 Therapy in Resource-limited Settings

Background: Convenient dosing, potency, and low toxicity profile support use of tenofovir disoproxil fumarate (TDF) as the preferred first line nucleotide reverse transcriptase inhibitor (NRTI) in combination regimens for HIV-1 treatment. However, renal and metabolic safety of TDF compared to other NRTI in resource-limited settings has not been well described. Methodology: Secondary analysis within the…

Risk Factors for Atazanavir (ATV)-Associated Urolithiasis: A Case-Control Study

Background: Urolithiasis have been reported in patients treated with ATV. Risk factors, clinical features and outcome of ATV-associated urolithiasis have not been fully investigated. Methodology: From January 2008 to December 2012, we collected all cases of ATV-associated urolithiasis among HIV-infected patients receiving ATV-containing regimens in Paris. A case-control study was then performed with cases defined…

Single Nucleotide Polymorphisms in UGT1A1 Associate with Atazanavir-related Nephrolithiasis

Background: Ritonavir-boosted atazanavir (ATV/r) is a widely used antiretroviral drug though it can cause nephrolithiasis. The aim of this study was to determine the association between polymorphisms in genes encoding proteins that take part in metabolizing process of ATV and drug transporters, and ATV/r-associated nephrolithiasis in HIV-1-infected patients treated with ATV/r. Methodology: The 20 single…

End-Stage Kidney Disease and Kidney Transplantation in HIV-Positive Patients

Background: HIV positive individuals are at increased risk of end-stage kidney disease (ESKD). We describe the clinical epidemiology and outcomes of HIV/ESKD in the UK CHIC Study including eligibility for and use of kidney transplantation (KT). Methodology: Observational cohort study of patients in UK CHIC who received permanent renal replacement therapy between 01/2000 and 12/2011,…

Antiretroviral Adherence Associated With Reduced Breastmilk HIV-1 Transmission: The BAN Study

Background: Postnatal HIV-1 transmission occurred in the Breastfeeding, Antiretrovirals and Nutrition (BAN) study despite well-controlled implementation of either maternal antiretrovirals (ARV) or daily infant nevirapine (NVP) throughout 28 weeks of breastfeeding. One possible explanation for transmission is suboptimal adherence to prescribed antiretrovirals. Quantifying the association between adherence and breastmilk HIV-1 transmission will have significant practical…

Cytomegalovirus and Possibly Epstein-Barr Virus in Breast Milk May Facilitate HIV-1 Transmission

Background: HIV-1 mother-to-child transmission (MTCT) occurs despite antiretroviral treatment (ART), including through breastfeeding, although the exact mechanisms remain largely unknown. Since the vast majority of breastfed infants of HIV-1 infected mothers escape infection even in the absence of ART, some factors must drive HIV-1 transmission by breastfeeding. Co-infections including Cytomegalovirus (CMV) and Epstein-Barr virus (EBV),…